Enovis Corporation (0I1B.L)
| Previous close | 46.52 |
| Open | 46.26 |
| Bid | N/A x N/A |
| Ask | 0.00 x N/A |
| Day's range | 46.26 - 47.19 |
| 52-week range | 43.31 - 65.36 |
| Volume | |
| Avg. volume | 26 |
| Market cap | N/A |
| Beta (5Y monthly) | 2.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireEnovis Announces Time Change for Second Quarter 2024 Results Conference Call
Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced a change in the scheduling of its upcoming earnings results conference call. The call will still take place on August 7, 2024, but will now be held at 8:00 a.m. Eastern Time, instead of the previously announced time. There is no change to the date, the dial-in or webcasting information. A presentation related to the call will be available on ir.en
Simply Wall St.Investors in Enovis (NYSE:ENOV) have unfortunately lost 41% over the last three years
As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...
ZacksSelect Medical's (SEM) Unit Begins IPO Roadshow for 22.5M Shares
Select Medical's (SEM) subsidiary, Concentra, starts roadshow for IPO of 22.5 million shares, aiming to list on the NYSE under ticker "CON" with an expected price range of $23-$26 per share.
